These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 536993)

  • 21. Replacement of the disulfide bond in oxytocin by an amide group. Synthesis and some biological properties of (cyclo-(1-L-aspartic acid,6-L-alpha,beta-diaminopropionic acid))oxytocin.
    Smith CW; Walter R; Moore S; Makofske RC; Meienhofer J
    J Med Chem; 1978 Jan; 21(1):117-20. PubMed ID: 619141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological activity of a biotinylated vasopressin analog.
    Lutz WH; Londowski JM; Kumar R
    Peptides; 1990; 11(4):687-91. PubMed ID: 2172938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antidiuretic activity of terlipressin (triglycyl-lysine vasopressin)--role of pressure natriuresis.
    Machová A
    Physiol Res; 1992; 41(2):121-7. PubMed ID: 1286075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conversion of triglycylvasopressin to lysine-vasopressin in man.
    Forsling ML; Aziz LA; Miller M; Davies R; Donovan B
    J Endocrinol; 1980 May; 85(2):237-44. PubMed ID: 7400711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal haemodynamic actions of pressor doses of lysine vasopressin in the rat.
    Lote CJ; McVicar AJ; Thewles A
    J Physiol; 1987 Oct; 391():407-18. PubMed ID: 3443952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of the substitution of photoreactive groups in positions 4 and 8 of vasopressin.
    Buku A; Yamin N; Gazis D
    Int J Pept Protein Res; 1989 Jul; 34(1):28-32. PubMed ID: 2507457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. (4-Phenylalanine)oxytocin, an inhibitor of the antidiuretic effect of 8-arginine-vasopressin.
    Nestor JJ; Ferger MF; Chan WY
    J Med Chem; 1975 Oct; 18(10):1022-4. PubMed ID: 1159680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design of potent antagonists of the vasopressor response to arginine-vasopressin.
    Bankowski K; Manning M; Haldar J; Sawyer WH
    J Med Chem; 1978 Sep; 21(9):850-3. PubMed ID: 722751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and biological activities of arginine-vasopressin analogues with 4-hydroxyproline in position 7.
    Buku A; Schwartz IL; Yamin N; Wyssbrod HR; Gazis D
    J Med Chem; 1987 Aug; 30(8):1509-12. PubMed ID: 3612693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-Acetyl-[2-(O-methyl)tyrosine]arginine-vasopressin, an interesting antagonist of the vasopressor response to vasopressin.
    Jones DA; Sawyer WH
    J Med Chem; 1980 Jun; 23(6):696-8. PubMed ID: 7392038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 4-Proline and 4-hydroxyproline analogs of arginine vasopressin: role of the proline substitution in the two beta-turns of vasopressin.
    Buku A; Yamin N; Gazis D
    Experientia; 1987 Dec; 43(11-12):1218-9. PubMed ID: 3691742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological effects of introducing a double bond into a binding site of oxytocin. Analogues with L-3,4-dehydroproline in position 7.
    Moore S; Felix AM; Meienhofer J; Smith CW; Walter R
    J Med Chem; 1977 Apr; 20(4):495-500. PubMed ID: 850234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and biological activities of a fluorescent photoaffinity analog of vasopressin.
    Buku A; Schwartz IL; Gazis D; Ma CL; Eggena P
    Endocrinology; 1985 Jul; 117(1):196-200. PubMed ID: 3924578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potent antagonists of the antidiuretic responses to arginine-vasopressin based on modifications of [1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid),2-D- phenylalanine,4-valine]arginine-vasopressin at position 4.
    Manning M; Olma A; Klis WA; Seto J; Sawyer WH
    J Med Chem; 1983 Nov; 26(11):1607-13. PubMed ID: 6631916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A conformationally constrained vasopressin analog with antidiuretic antagonistic activity.
    Skala G; Smith CW; Taylor CJ; Ludens JH
    Science; 1984 Oct; 226(4673):443-5. PubMed ID: 6541806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and binding characteristics of two sulfhydryl-reactive probes for vasopressin receptors.
    Pávó I; Kojro E; Fahrenholz F
    FEBS Lett; 1993 Jan; 316(1):59-62. PubMed ID: 8422939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of vasopressin on the human non-pregnant uterus: studies with analogues of different vasopressor potencies.
    Melin P; Trojnar J; Carlsson AM; Bengtsson B; Akerlund M; Robinson I
    Eur J Pharmacol; 1988 Mar; 148(1):93-9. PubMed ID: 3383999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [1-(L-2-hydroxy-3-mercaptopropanoic acid)] analogues of arginine-vasopressin, [8-D-arginine]vasopressin, and [4-valine,8-D-arginine]vasopressin.
    Lowbridge J; Manning M; Haldar J; Sawyer W
    J Med Chem; 1977 Sep; 20(9):1173-6. PubMed ID: 926117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potent and selective antagonists of the antidiuretic responses to arginine-vasopressin based on modifications of [1-(beta-mercapto-beta,beta-pentamethylenepropionic acid),2-D-isoleucine,4- valine]arginine-vasopressin at position 4.
    Manning M; Nawrocka E; Misicka A; Olma A; Klis WA; Seto J; Sawyer WH
    J Med Chem; 1984 Apr; 27(4):423-9. PubMed ID: 6708045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxytocin analogues with combined high smooth muscle and negligible antidiuretic activities. Investigation of position 7 in neurohypophyseal hormones.
    Walter R; Smith CW; Roy J; Formento A
    J Med Chem; 1976 Jun; 19(6):822-5. PubMed ID: 985884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.